Erectile function was assessed by measuring the ratio of peak intracavernous pressure (ICP) to mean arterial pressure (MAP), and tissues were harvested for transmission electron microscopy, immunofluorescence, Masson’s trichrome staining, TUNEL staining, and Western blot analysis. LCM was injected intraperitoneally at a dose of 90 mg/kg/day for 7 consecutive days.

To explore whether LCM can improve the erectile response after BCNI, we randomly divided 30 young Sprague-Dawley rats into three groups ( n = 10 per group), namely, the sham operation, 0.9% normal saline-treated (BCNI + 0.9% NS), and LCM-treated BCNI (BCNI + LCM) groups. Furthermore, lacosamide (LCM) can alleviate peripheral neuropathy. Requests may be made directly to and every effort will be made to honor them within 48 hours.Bilateral cavernous nerve injury-related erectile dysfunction (BCNI-ED) shows a limited response to type 5 phosphodiesterase inhibitors. This policy allows verified trademark owners to specify: (A) that their identifiable information be masked, or (B) that their trademark pages permanently deleted from. Such requests must be made in writing and will be subject to verification of ownership. You may also contact Trademarkia to make a request for the removal of your personally identifiable information or trademark data.

Our website will auto-update when the USPTO data is updated. Since our website is synchronized with the USPTO data, we recommend making any data changes with the USPTO directly. The USPTO makes this data available for search by the public so that individuals can locate ownership information for intellectual property, much the same way a county might make real estate property ownership information available. Why is this contact information displayed?

Graphpad software inc